APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Adipose Tissue-derived Stem Cell Therapy

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Adipose Tissue-derived Stem Cell Therapy Industry Growth and Trends Forecast to 2032

Report ID 173960730119 December 2025111 pages

Choose your research edition.

Industry ResearchAdipose Tissue-derived Stem Cell Therapy Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Adipose Tissue-derived Stem Cell Therapy Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Adipose Tissue-derived Stem Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Adipose Tissue-derived Stem Cell Therapy Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Adipose Tissue-derived Stem Cell Therapy Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

According to APO Research, the global Adipose Tissue-derived Stem Cell Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Adipose Tissue-derived Stem Cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Adipose Tissue-derived Stem Cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Adipose Tissue-derived Stem Cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Adipose Tissue-derived Stem Cell Therapy market include Lonza, Tissue Genesis, Pluristem Therapeutics, Pluristem Therapeutics, Mesoblast, iXCells Biotechnologies, Intrexon, Cytori Therapeutics and Cyagen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Adipose Tissue-derived Stem Cell Therapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Adipose Tissue-derived Stem Cell Therapy market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Adipose Tissue-derived Stem Cell Therapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Adipose Tissue-derived Stem Cell Therapy.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Adipose Tissue-derived Stem Cell Therapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Adipose Tissue-derived Stem Cell Therapy Market by Company

Lonza

Tissue Genesis

Pluristem Therapeutics

Pluristem Therapeutics

Mesoblast

iXCells Biotechnologies

Intrexon

Cytori Therapeutics

Cyagen

Corestem

Celltex Therapeutics Corporation

Cellleris

Celgene Corporation

BioRestorative Therapies

Antria

AlloCure

Adipose Tissue-derived Stem Cell Therapy Segment by Type

Autologous Stem Cells

Allogeneic Stem Cells

Adipose Tissue-derived Stem Cell Therapy Segment by Application

Therapeutic Application

Research Application

Adipose Tissue-derived Stem Cell Therapy Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adipose Tissue-derived Stem Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Adipose Tissue-derived Stem Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adipose Tissue-derived Stem Cell Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Adipose Tissue-derived Stem Cell Therapy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Adipose Tissue-derived Stem Cell Therapy Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Region (2021-2026) Table 4. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Region (2027-2032) Table 6. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Adipose Tissue-derived Stem Cell Therapy Market Size Share by Type (2021-2026) Table 9. Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Adipose Tissue-derived Stem Cell Therapy Market Size Share Forecasted by Type (2027-2032) Table 11. North America Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Adipose Tissue-derived Stem Cell Therapy Market Size Share by Application (2021-2026) Table 24. Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Adipose Tissue-derived Stem Cell Therapy Market Size Share Forecasted by Application (2027-2032) Table 26. North America Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Adipose Tissue-derived Stem Cell Therapy Industry Trends Table 37. Adipose Tissue-derived Stem Cell Therapy Industry Drivers Table 38. Adipose Tissue-derived Stem Cell Therapy Industry Opportunities and Challenges Table 39. Adipose Tissue-derived Stem Cell Therapy Industry Restraints Table 40. Global Adipose Tissue-derived Stem Cell Therapy Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Company (2021-2026) Table 42. Global Adipose Tissue-derived Stem Cell Therapy Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Adipose Tissue-derived Stem Cell Therapy Key Company Headquarters & Area Served Table 44. Global Adipose Tissue-derived Stem Cell Therapy Company, Product Type & Application Table 45. Global Adipose Tissue-derived Stem Cell Therapy Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Adipose Tissue-derived Stem Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Lonza Company Information Table 49. Lonza Business Overview Table 50. Lonza Adipose Tissue-derived Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Lonza Adipose Tissue-derived Stem Cell Therapy Product Portfolio Table 52. Lonza Recent Development Table 53. Tissue Genesis Company Information Table 54. Tissue Genesis Business Overview Table 55. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product Portfolio Table 57. Tissue Genesis Recent Development Table 58. Pluristem Therapeutics Company Information Table 59. Pluristem Therapeutics Business Overview Table 60. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Portfolio Table 62. Pluristem Therapeutics Recent Development Table 63. Pluristem Therapeutics Company Information Table 64. Pluristem Therapeutics Business Overview Table 65. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Portfolio Table 67. Pluristem Therapeutics Recent Development Table 68. Mesoblast Company Information Table 69. Mesoblast Business Overview Table 70. Mesoblast Adipose Tissue-derived Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Mesoblast Adipose Tissue-derived Stem Cell Therapy Product Portfolio Table 72. Mesoblast Recent Development Table 73. iXCells Biotechnologies Company Information Table 74. iXCells Biotechnologies Business Overview Table 75. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product Portfolio Table 77. iXCells Biotechnologies Recent Development Table 78. Intrexon Company Information Table 79. Intrexon Business Overview Table 80. Intrexon Adipose Tissue-derived Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Intrexon Adipose Tissue-derived Stem Cell Therapy Product Portfolio Table 82. Intrexon Recent Development Table 83. Cytori Therapeutics Company Information Table 84. Cytori Therapeutics Business Overview Table 85. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Portfolio Table 87. Cytori Therapeutics Recent Development Table 88. Cyagen Company Information Table 89. Cyagen Business Overview Table 90. Cyagen Adipose Tissue-derived Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Cyagen Adipose Tissue-derived Stem Cell Therapy Product Portfolio Table 92. Cyagen Recent Development Table 93. Corestem Company Information Table 94. Corestem Business Overview Table 95. Corestem Adipose Tissue-derived Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Corestem Adipose Tissue-derived Stem Cell Therapy Product Portfolio Table 97. Corestem Recent Development Table 98. Celltex Therapeutics Corporation Company Information Table 99. Celltex Therapeutics Corporation Business Overview Table 100. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product Portfolio Table 102. Celltex Therapeutics Corporation Recent Development Table 103. Cellleris Company Information Table 104. Cellleris Business Overview Table 105. Cellleris Adipose Tissue-derived Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Cellleris Adipose Tissue-derived Stem Cell Therapy Product Portfolio Table 107. Cellleris Recent Development Table 108. Celgene Corporation Company Information Table 109. Celgene Corporation Business Overview Table 110. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product Portfolio Table 112. Celgene Corporation Recent Development Table 113. BioRestorative Therapies Company Information Table 114. BioRestorative Therapies Business Overview Table 115. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product Portfolio Table 117. BioRestorative Therapies Recent Development Table 118. Antria Company Information Table 119. Antria Business Overview Table 120. Antria Adipose Tissue-derived Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Antria Adipose Tissue-derived Stem Cell Therapy Product Portfolio Table 122. Antria Recent Development Table 123. AlloCure Company Information Table 124. AlloCure Business Overview Table 125. AlloCure Adipose Tissue-derived Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. AlloCure Adipose Tissue-derived Stem Cell Therapy Product Portfolio Table 127. AlloCure Recent Development Table 128. North America Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2021-2026) Table 131. North America Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Adipose Tissue-derived Stem Cell Therapy Market Share Forecast by Country (2027-2032) Table 133. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2021-2026) Table 136. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Adipose Tissue-derived Stem Cell Therapy Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2021-2026) Table 141. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Share Forecast by Country (2027-2032) Table 143. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2021-2026) Table 146. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Adipose Tissue-derived Stem Cell Therapy Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2021-2026) Table 151. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Adipose Tissue-derived Stem Cell Therapy Product Image Figure 3. Global Adipose Tissue-derived Stem Cell Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Adipose Tissue-derived Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 5. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Region: 2025 VS 2032 Figure 6. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Region (2021-2032) Figure 7. North America Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Autologous Stem Cells Image Figure 13. Global Autologous Stem Cells Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Allogeneic Stem Cells Image Figure 15. Global Allogeneic Stem Cells Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Adipose Tissue-derived Stem Cell Therapy Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Type 2025 VS 2032 Figure 18. North America Adipose Tissue-derived Stem Cell Therapy Market Size Share by Type (2021-2032) Figure 19. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size Share by Type (2021-2032) Figure 21. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Market Size Share by Type (2021-2032) Figure 23. Therapeutic Application Image Figure 24. Global Therapeutic Application Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Research Application Image Figure 26. Global Research Application Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Global Adipose Tissue-derived Stem Cell Therapy Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Application 2025 VS 2032 Figure 29. North America Adipose Tissue-derived Stem Cell Therapy Market Size Share by Application (2021-2032) Figure 30. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Share by Application (2021-2032) Figure 31. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size Share by Application (2021-2032) Figure 32. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size Share by Application (2021-2032) Figure 33. Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Market Size Share by Application (2021-2032) Figure 34. Global Top 5 and 10 Adipose Tissue-derived Stem Cell Therapy Players Market Share by Revenue in 2025 Figure 35. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. North America Adipose Tissue-derived Stem Cell Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 37. North America Adipose Tissue-derived Stem Cell Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 38. North America Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2021-2032) Figure 39. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 40. Europe Adipose Tissue-derived Stem Cell Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 41. Europe Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2021-2032) Figure 42. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2021-2032) Figure 45. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Latin America Adipose Tissue-derived Stem Cell Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Latin America Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2021-2032) Figure 48. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2021-2032) Figure 51. Years Considered Figure 52. Research Process Figure 53. Key Executives Interviewed

Scope & coverage.

Types
  • Autologous Stem Cells
  • Allogeneic Stem Cells
Applications
  • Therapeutic Application
  • Research Application
Companies covered
  • Lonza
  • Tissue Genesis
  • Pluristem Therapeutics
  • Pluristem Therapeutics
  • Mesoblast
  • iXCells Biotechnologies
  • Intrexon
  • Cytori Therapeutics
  • Cyagen
  • Corestem
  • Celltex Therapeutics Corporation
  • Cellleris
  • Celgene Corporation
  • BioRestorative Therapies
  • Antria
  • AlloCure

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Adipose Tissue-derived Stem Cell Therapy Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2021-2032)
  5. 1.4.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2021-2026)
  6. 1.4.2 Global Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2027-2032)
  7. 1.5 Key Regions Adipose Tissue-derived Stem Cell Therapy Market Size (2021-2032)
  8. 1.5.1 North America Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate (2021-2032)
2 Adipose Tissue-derived Stem Cell Therapy Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Autologous Stem Cells
  3. 2.1.2 Allogeneic Stem Cells
  4. 2.2 Global Adipose Tissue-derived Stem Cell Therapy Market Size by Type
  5. 2.2.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Adipose Tissue-derived Stem Cell Therapy Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Adipose Tissue-derived Stem Cell Therapy Market Size by Regions
  9. 2.3.1 North America Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Type (2021-2026)
3 Adipose Tissue-derived Stem Cell Therapy Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Therapeutic Application
  3. 3.1.2 Research Application
  4. 3.2 Global Adipose Tissue-derived Stem Cell Therapy Market Size by Application
  5. 3.2.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Adipose Tissue-derived Stem Cell Therapy Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Adipose Tissue-derived Stem Cell Therapy Market Size by Regions
  9. 3.3.1 North America Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Adipose Tissue-derived Stem Cell Therapy Industry Trends
  2. 4.2 Adipose Tissue-derived Stem Cell Therapy Industry Drivers
  3. 4.3 Adipose Tissue-derived Stem Cell Therapy Industry Opportunities and Challenges
  4. 4.4 Adipose Tissue-derived Stem Cell Therapy Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Adipose Tissue-derived Stem Cell Therapy Revenue (2021-2026)
  2. 5.2 Global Adipose Tissue-derived Stem Cell Therapy Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Adipose Tissue-derived Stem Cell Therapy Key Company Headquarters & Area Served
  4. 5.4 Global Adipose Tissue-derived Stem Cell Therapy Company, Product Type & Application
  5. 5.5 Global Adipose Tissue-derived Stem Cell Therapy Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Adipose Tissue-derived Stem Cell Therapy Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Adipose Tissue-derived Stem Cell Therapy Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Adipose Tissue-derived Stem Cell Therapy Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Lonza
  2. 6.1.1 Lonza Company Information
  3. 6.1.2 Lonza Business Overview
  4. 6.1.3 Lonza Adipose Tissue-derived Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Lonza Adipose Tissue-derived Stem Cell Therapy Product Portfolio
  6. 6.1.5 Lonza Recent Developments
  7. 6.2 Tissue Genesis
  8. 6.2.1 Tissue Genesis Company Information
  9. 6.2.2 Tissue Genesis Business Overview
  10. 6.2.3 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product Portfolio
  12. 6.2.5 Tissue Genesis Recent Developments
  13. 6.3 Pluristem Therapeutics
  14. 6.3.1 Pluristem Therapeutics Company Information
  15. 6.3.2 Pluristem Therapeutics Business Overview
  16. 6.3.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Portfolio
  18. 6.3.5 Pluristem Therapeutics Recent Developments
  19. 6.4 Pluristem Therapeutics
  20. 6.4.1 Pluristem Therapeutics Company Information
  21. 6.4.2 Pluristem Therapeutics Business Overview
  22. 6.4.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Portfolio
  24. 6.4.5 Pluristem Therapeutics Recent Developments
  25. 6.5 Mesoblast
  26. 6.5.1 Mesoblast Company Information
  27. 6.5.2 Mesoblast Business Overview
  28. 6.5.3 Mesoblast Adipose Tissue-derived Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Mesoblast Adipose Tissue-derived Stem Cell Therapy Product Portfolio
  30. 6.5.5 Mesoblast Recent Developments
  31. 6.6 iXCells Biotechnologies
  32. 6.6.1 iXCells Biotechnologies Company Information
  33. 6.6.2 iXCells Biotechnologies Business Overview
  34. 6.6.3 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product Portfolio
  36. 6.6.5 iXCells Biotechnologies Recent Developments
  37. 6.7 Intrexon
  38. 6.7.1 Intrexon Company Information
  39. 6.7.2 Intrexon Business Overview
  40. 6.7.3 Intrexon Adipose Tissue-derived Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Intrexon Adipose Tissue-derived Stem Cell Therapy Product Portfolio
  42. 6.7.5 Intrexon Recent Developments
  43. 6.8 Cytori Therapeutics
  44. 6.8.1 Cytori Therapeutics Company Information
  45. 6.8.2 Cytori Therapeutics Business Overview
  46. 6.8.3 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Portfolio
  48. 6.8.5 Cytori Therapeutics Recent Developments
  49. 6.9 Cyagen
  50. 6.9.1 Cyagen Company Information
  51. 6.9.2 Cyagen Business Overview
  52. 6.9.3 Cyagen Adipose Tissue-derived Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Cyagen Adipose Tissue-derived Stem Cell Therapy Product Portfolio
  54. 6.9.5 Cyagen Recent Developments
  55. 6.10 Corestem
  56. 6.10.1 Corestem Company Information
  57. 6.10.2 Corestem Business Overview
  58. 6.10.3 Corestem Adipose Tissue-derived Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Corestem Adipose Tissue-derived Stem Cell Therapy Product Portfolio
  60. 6.10.5 Corestem Recent Developments
  61. 6.11 Celltex Therapeutics Corporation
  62. 6.11.1 Celltex Therapeutics Corporation Company Information
  63. 6.11.2 Celltex Therapeutics Corporation Business Overview
  64. 6.11.3 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product Portfolio
  66. 6.11.5 Celltex Therapeutics Corporation Recent Developments
  67. 6.12 Cellleris
  68. 6.12.1 Cellleris Company Information
  69. 6.12.2 Cellleris Business Overview
  70. 6.12.3 Cellleris Adipose Tissue-derived Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Cellleris Adipose Tissue-derived Stem Cell Therapy Product Portfolio
  72. 6.12.5 Cellleris Recent Developments
  73. 6.13 Celgene Corporation
  74. 6.13.1 Celgene Corporation Company Information
  75. 6.13.2 Celgene Corporation Business Overview
  76. 6.13.3 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product Portfolio
  78. 6.13.5 Celgene Corporation Recent Developments
  79. 6.14 BioRestorative Therapies
  80. 6.14.1 BioRestorative Therapies Company Information
  81. 6.14.2 BioRestorative Therapies Business Overview
  82. 6.14.3 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product Portfolio
  84. 6.14.5 BioRestorative Therapies Recent Developments
  85. 6.15 Antria
  86. 6.15.1 Antria Company Information
  87. 6.15.2 Antria Business Overview
  88. 6.15.3 Antria Adipose Tissue-derived Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Antria Adipose Tissue-derived Stem Cell Therapy Product Portfolio
  90. 6.15.5 Antria Recent Developments
  91. 6.16 AlloCure
  92. 6.16.1 AlloCure Company Information
  93. 6.16.2 AlloCure Business Overview
  94. 6.16.3 AlloCure Adipose Tissue-derived Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 AlloCure Adipose Tissue-derived Stem Cell Therapy Product Portfolio
  96. 6.16.5 AlloCure Recent Developments
7 North America
  1. 7.1 North America Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2021-2026)
  3. 7.3 North America Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2021-2026)
  3. 8.3 Europe Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2021-2026)
  3. 10.3 South America Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst